Lupron Depot Kit
Product Images NDC 0074-3641

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Lupron Depot (NDC 0074-3641). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lupron Depot 3 75mg 01

Illustration of the Lupron Depot kit syringe showing labeled parts including plunger, finger grip, end stopper, middle stoppers, barrel containing leuprolide acetate microsphere powder and diluent, front stopper, a blue line, needle and cap, and the LuproLoc safety device.*

FDA Label Image

Lupron Depot 3 75mg 02

An instructional illustration showing hands manipulating a medical device. The image depicts a syringe being twisted or connected to another component, likely demonstrating assembly or preparation steps for administering medication from a Lupron Depot kit.*

FDA Label Image

Lupron Depot 3 75mg 03

An instructional line drawing showing a hand holding a syringe with a visible blue line near the top. An arrow points upward from the syringe plunger, and another arrow points to the blue line, indicating a step in the injection preparation process.*

FDA Label Image

Lupron Depot 3 75mg 04

An instructional illustration showing a hand holding a syringe and moving the plunger back and forth, indicated by bi-directional arrows around the plunger. This likely demonstrates how to prepare or mix the injection before use.*

FDA Label Image

Lupron Depot 3 75mg 05

An instructional illustration showing a hand holding a syringe with the needle pointing downward, positioned at a right angle to a flat surface, possibly demonstrating an injection technique.*

FDA Label Image

Lupron Depot 3 75mg 06

An instructional diagram showing a syringe with a callout box explaining that if a blood vessel is injured during injection, blood will be visible in a specific section of the syringe to indicate this. The image highlights safety or administration verification for Lupron Depot kit injections.*

FDA Label Image

Lupron Depot 3 75mg 07

An instructional illustration with three step-by-step line drawings showing how to operate a syringe or medical device. Each image depicts a hand gripping the device and pulling upward with arrows indicating the direction. The final step shows the plunger being pulled until a 'CLICK' sound occurs, demonstrating proper handling or activation of the device.*

FDA Label Image

Lupron Depot 3 75mg 08

Chemical structure diagram of leuprolide acetate, the active ingredient in Lupron Depot. The diagram shows the molecular arrangement of atoms and bonds representing the peptide structure.*

FDA Label Image

Lupron Depot 3 75mg 09

A bar chart presenting patient-reported symptoms at different time points: baseline, final treatment visit, 6 months, and 12 months follow-up. Symptoms include pelvic pain, dyspareunia, pelvic tenderness, induration, and dysmenorrhea, with percentage values shown on the vertical axis. The chart compares symptom prevalence over time in a study population.*

FDA Label Image

Lupron Depot 3 75mg 0a

Lupron Depot 3.75 mg kit for 1-month administration by AbbVie Inc. The label specifies the product is a single-dose administration kit containing leuprolide acetate for depot suspension. It includes components like a prefilled dual-chamber syringe for intramuscular injection and instructions for use. The label also provides lot number, expiration date, storage instructions, and usage precautions for adult use only.*

FDA Label Image

Lupron Depot 3 75mg 0b

Lupron Depot kit label showing 3.75 mg dosage for 1-month administration containing leuprolide acetate for depot suspension. The label indicates it is for adult use and intramuscular injection. The product is by AbbVie Inc. and includes a prefilled dual-chamber syringe and related components. The NDC is 0074-3641.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.